<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04897308</url>
  </required_header>
  <id_info>
    <org_study_id>Soh-Med-21-05-04</org_study_id>
    <nct_id>NCT04897308</nct_id>
  </id_info>
  <brief_title>Best Treatment Modality of Frozen Shoulder</brief_title>
  <official_title>Shoulder Adhesive Capsulitis ; Comparison Between Three Theraputic Approaches</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare between the effect of three treatment modalities of shoulder adhesive&#xD;
      capsulitis to hilight the best technique to improve pain and range of motion outcome measures&#xD;
      .&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2021</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in range of motion of shoulder joint</measure>
    <time_frame>12 weeks efter intervention</time_frame>
    <description>Improvement will be measured by measuring active and passive range of motion</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Improvement in pain</measure>
    <time_frame>12 weeks after intervention</time_frame>
    <description>Improvement will be measured by VAS ( visual auditory assessment )</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Shoulder Adhesive Capsulitis</condition>
  <arm_group>
    <arm_group_label>Suprascapular nerve block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will include will under go suprascapularnerve block as following :10 ml of .5% bupivacaine and 2 ml of methylpradnisolon 40mg/ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hydrodilatation of shoulder capsule</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will undergo intraarticular hydrodilatation by injection of :first lidocaine10ml%followed by 1ml of methylprednisolon 40mg/ml and finally 20ml of .9 % sodium chloride slowly in the gleno humeral joint</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hydrodilatation of shoulder interval</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will undergo interval hydrodilatation by injection of :first mepivacaine 10ml folowed by 20ml of sterile water slowly in the shoulder interval</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Local injection of shoulder joint</intervention_name>
    <description>Under ultrasound guidance , local shoulder joint injection will be done</description>
    <arm_group_label>Hydrodilatation of shoulder capsule</arm_group_label>
    <arm_group_label>Hydrodilatation of shoulder interval</arm_group_label>
    <arm_group_label>Suprascapular nerve block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  gross limitation of passive shoulder movement&#xD;
&#xD;
          -  pain interfering with daily activities&#xD;
&#xD;
          -  painful restiction of active and passive movement of shoulder&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  presence of degenerative pathology&#xD;
&#xD;
          -  fracture&#xD;
&#xD;
          -  contraindication to steroid injection&#xD;
&#xD;
          -  deformity affecting upper limb&#xD;
&#xD;
          -  history of previous shoulder injection in the past 4 weeks&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shorouk Mohamed</last_name>
    <phone>01117706686</phone>
    <email>Shrouk011107@med.sohag.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sohag faculty</name>
      <address>
        <city>Sohag</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shorouk Mohamed</last_name>
      <phone>01117706686</phone>
      <email>Shrouk011107@med.sohag.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 16, 2021</study_first_submitted>
  <study_first_submitted_qc>May 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2021</study_first_posted>
  <last_update_submitted>May 18, 2021</last_update_submitted>
  <last_update_submitted_qc>May 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>Shorouk Ayman Mohamed</investigator_full_name>
    <investigator_title>Resident doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bursitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

